T-DXd
Breast Cancer Drug Showing High Rates of Activity in HER2+ Lung and Gastric Cancers
A new-generation antibody drug conjugate approved for the treatment of HER2-positive breast cancer demonstrated ...
JANUARY 4, 2022
New Antibody Drug Conjugate May Become Metastatic Breast Cancer Standard
For second-line treatment of metastatic HER2-positive breast cancer, the new-generation antibody drug conjugate ...
DECEMBER 16, 2021
Load more